Skip to Content

790 Results Found

  • Review
  • Open Access
11 Citations
6,836 Views
15 Pages

Cyclic Peptide-Based Biologics Regulating HGF-MET

  • Hiroki Sato,
  • Ryu Imamura,
  • Hiroaki Suga,
  • Kunio Matsumoto and
  • Katsuya Sakai

27 October 2020

Using a random non-standard peptide integrated discovery system, we obtained cyclic peptides that bind to hepatocyte growth factor (HGF) or mesenchymal-epithelial transition factor. (MET) HGF-inhibitory peptide-8 (HiP-8) selectively bound to two-chai...

(This article belongs to the Special Issue Hepatocyte Growth Factor (HGF), II)
  • Review
  • Open Access
92 Citations
11,677 Views
17 Pages

3 December 2018

Hepatocyte growth factor (HGF)/ mesenchymal-epithelial transition factor (c-MET) signaling is involved in complex cellular programs that are important for embryonic development and tissue regeneration, but its activity is also utilized by cancer cell...

(This article belongs to the Special Issue Hepatocyte Growth Factor (HGF))
  • Review
  • Open Access
88 Citations
16,274 Views
26 Pages

HGF–Met Pathway in Regeneration and Drug Discovery

  • Kunio Matsumoto,
  • Hiroshi Funakoshi,
  • Hisaaki Takahashi and
  • Katsuya Sakai

31 October 2014

Hepatocyte growth factor (HGF) is composed of an α-chain and a β-chain, and these chains contain four kringle domains and a serine protease-like structure, respectively. Activation of the HGF–Met pathway evokes dynamic biological responses that supp...

(This article belongs to the Special Issue New aspects of the Hepatocyte Growth Factor/c-Met System)
  • Review
  • Open Access
33 Citations
5,283 Views
15 Pages

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma

  • Ryota Tanaka,
  • Mizue Terai,
  • Eric Londin and
  • Takami Sato

30 October 2021

Hepatocyte growth factor (HGF)/mesenchymal-epithelial transition factor (MET) signaling promotes tumorigenesis and tumor progression in various types of cancer, including uveal melanoma (UM). The roles of HGF/MET signaling have been studied in cell s...

(This article belongs to the Special Issue Metastatic Uveal Melanoma)
  • Article
  • Open Access
2 Citations
1,675 Views
13 Pages

Identification of Novel Compounds That Bind to the HGF β-Chain In Silico, Verification by Molecular Mechanics and Quantum Mechanics, and Validation of Their HGF Inhibitory Activity In Vitro

  • Ko Suzuki,
  • Keitaro Inoue,
  • Ryota Namiguchi,
  • Seiya Morita and ,
  • Suzuho Hayakawa,
  • Mikuri Yokota,
  • Katsuya Sakai,
  • Kunio Matsumoto and
  • Shunsuke Aoki
  • + 4 authors+ 0 author

17 April 2025

The development of small-molecule drugs targeting growth factors for cancer therapy remains a significant challenge, with only limited successful cases. We attempted to identify hepatocyte growth factor (HGF) inhibitors as novel anti-cancer small-mol...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
15 Citations
7,896 Views
14 Pages

Distinct Localization of Mature HGF from its Precursor Form in Developing and Repairing the Stomach

  • Nawaphat Jangphattananont,
  • Hiroki Sato,
  • Ryu Imamura,
  • Katsuya Sakai and ,
  • Yumi Terakado,
  • Kazuhiro Murakami,
  • Nick Barker,
  • Hiroko Oshima,
  • Masanobu Oshima and
  • Kunio Matsumoto
  • + 8 authors+ 3 authors

Hepatocyte growth factor (HGF) is secreted as an inactive single-chain HGF (scHGF); however, only proteolytically processed two-chain HGF (tcHGF) can activate the MET receptor. We investigated the localization of tcHGF and activated/phosphorylated ME...

(This article belongs to the Special Issue Hepatocyte Growth Factor (HGF), II)
  • Review
  • Open Access
40 Citations
7,442 Views
18 Pages

HGF/MET Signaling in Malignant Brain Tumors

  • Elizabeth Qian Xu Mulcahy,
  • Rossymar Rivera Colόn and
  • Roger Abounader

13 October 2020

Hepatocyte growth factor (HGF) ligand and its receptor tyrosine kinase (RTK) mesenchymal-epithelial transition factor (MET) are important regulators of cellular processes such as proliferation, motility, angiogenesis, and tissue regeneration. In heal...

(This article belongs to the Special Issue Hepatocyte Growth Factor (HGF), II)
  • Review
  • Open Access
71 Citations
9,180 Views
18 Pages

Targeting HGF/c-MET Axis in Pancreatic Cancer

  • Srinivasa P. Pothula,
  • Zhihong Xu,
  • David Goldstein,
  • Romano C. Pirola and ,
  • Jeremy S. Wilson and
  • Minoti V. Apte
  • + 1 author+ 0 author

1 December 2020

Pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC/PC)) has been an aggressive disease that is associated with early metastases. It is characterized by dense and collagenous desmoplasia/stroma, predominantly produced by pancreatic stellate cel...

(This article belongs to the Special Issue Hepatocyte Growth Factor (HGF), II)
  • Review
  • Open Access
45 Citations
8,970 Views
17 Pages

HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers

  • Hongli Zhang,
  • Qingqing Feng,
  • Wei-Dong Chen and
  • Yan-Dong Wang

23 October 2018

The HGF/c-MET pathway is active in the development of digestive system cancers, indicating that inhibition of HGF/c-MET signaling may have therapeutic potential. Various HGF/c-MET signaling inhibitors, mainly c-MET inhibitors, have been tested in cli...

(This article belongs to the Special Issue Hepatocyte Growth Factor (HGF))
  • Article
  • Open Access
5 Citations
7,483 Views
21 Pages

HGF Modulates Actin Cytoskeleton Remodeling and Contraction in Testicular Myoid Cells

  • Angela Catizone,
  • Giulia Ricci,
  • Maria Caruso,
  • Michela Galdieri and ,
  • Katia Corano Scheri,
  • Virginia Di Paolo and
  • Rita Canipari
  • + 2 authors+ 0 author

28 January 2015

The presence of the HGF/Met system in the testicular myoid cells was first discovered by our group. However, the physiological role of this pathway remains poorly understood. We previously reported that HGF increases uPA secretion and TGF-β activatio...

(This article belongs to the Special Issue New aspects of the Hepatocyte Growth Factor/c-Met System)
  • Review
  • Open Access
29 Citations
15,301 Views
39 Pages

12 August 2014

Met is the receptor of hepatocyte growth factor (HGF), a cytoprotective cytokine. Disturbing the equilibrium between Met and its ligand may lead to inappropriate cell survival, accumulation of genetic abnormalities and eventually, malignancy. Abnorma...

(This article belongs to the Special Issue MET in Cancer)
  • Review
  • Open Access
64 Citations
9,489 Views
16 Pages

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma

  • Nichola Cruickshanks,
  • Ying Zhang,
  • Fang Yuan,
  • Mary Pahuski and ,
  • Myron Gibert and
  • Roger Abounader
  • + 1 author+ 0 author

11 July 2017

Glioblastoma (GBM) is a lethal brain tumor with dismal prognosis. Current therapeutic options, consisting of surgery, chemotherapy and radiation, have only served to marginally increase patient survival. Receptor tyrosine kinases (RTKs) are dysregula...

(This article belongs to the Special Issue Hepatocyte Growth Factor Pathway in Cancer)
  • Review
  • Open Access
16 Citations
12,205 Views
18 Pages

HGF/Met Signaling Is a Key Player in Malignant Mesothelioma Carcinogenesis

  • Giovanni Gaudino,
  • Haining Yang and
  • Michele Carbone

14 November 2014

Malignant mesothelioma (MM) is a highly aggressive cancer related to asbestos or erionite exposure and resistant to current therapies. Hepatocyte Growth Factor (HGF) and its tyrosine kinase receptor Met regulate cell growth, survival, motility/migrat...

(This article belongs to the Special Issue New aspects of the Hepatocyte Growth Factor/c-Met System)
  • Review
  • Open Access
62 Citations
11,932 Views
12 Pages

The invasion of cancer cells into surrounding tissue and the vasculature is essential for tumor metastasis. Increasing evidence indicates that hepatocyte growth factor (HGF) induces cancer cell migration and invasion. A broad spectrum of mechanisms u...

(This article belongs to the Special Issue Hepatocyte Growth Factor Pathway in Cancer)
  • Review
  • Open Access
73 Citations
12,663 Views
18 Pages

HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation

  • Anna Spina,
  • Valeria De Pasquale,
  • Giuliana Cerulo,
  • Pasquale Cocchiaro and ,
  • Rossella Della Morte,
  • Luigi Avallone and
  • Luigi Michele Pavone
  • + 2 authors+ 0 author

Tumor metastases are responsible for approximately 90% of all cancer-related deaths. Metastasis formation is a multistep process that requires acquisition by tumor cells of a malignant phenotype that allows them to escape from the primary tumor site...

(This article belongs to the Special Issue New aspects of the Hepatocyte Growth Factor/c-Met System)
  • Review
  • Open Access
64 Citations
7,271 Views
18 Pages

Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer

  • Oshin Miranda,
  • Mariya Farooqui and
  • Jill M. Siegfried

21 August 2018

Hepatocyte growth factor (HGF) is the ligand for the tyrosine kinase receptor c-Met (Mesenchymal Epithelial Transition Factor also known as Hepatocyte Growth Factor Receptor, HGFR), a receptor with expression throughout epithelial and endothelial cel...

(This article belongs to the Special Issue Hepatocyte Growth Factor Pathway in Cancer)
  • Review
  • Open Access
33 Citations
14,389 Views
33 Pages

The hepatocyte growth factor (HGF): MET axis is a ligand-mediated receptor tyrosine kinase pathway that is involved in multiple cellular functions, including proliferation, survival, motility, and morphogenesis. Aberrancy in the HGF/MET pathway has b...

(This article belongs to the Special Issue New aspects of the Hepatocyte Growth Factor/c-Met System)
  • Review
  • Open Access
96 Citations
8,448 Views
13 Pages

HGF/MET and the Immune System: Relevance for Cancer Immunotherapy

  • Federica Papaccio,
  • Carminia Maria Della Corte,
  • Giuseppe Viscardi,
  • Raimondo Di Liello and ,
  • Giovanna Esposito,
  • Francesca Sparano,
  • Fortunato Ciardiello and
  • Floriana Morgillo
  • + 3 authors+ 0 author

14 November 2018

An overactivation of hepatocyte growth factor (HGF)/mesenchymal-epithelial transition factor (MET) axis promotes tumorigenesis and tumor progression in various cancer types. Research data recently evidenced that HGF/MET signaling is also involved als...

(This article belongs to the Special Issue Hepatocyte Growth Factor (HGF))
  • Review
  • Open Access
21 Citations
8,387 Views
12 Pages

24 October 2014

The MET oncogene encodes for Met protein, a trans-membrane tyrosine kinase identified as the high affinity receptor for hepatocyte growth factor (HGF). Immunohistochemical studies have demonstrated that Met protein is intensely expressed in tumor ce...

(This article belongs to the Special Issue New aspects of the Hepatocyte Growth Factor/c-Met System)
  • Article
  • Open Access
5 Citations
3,811 Views
14 Pages

Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation

  • Yumiko Tahira,
  • Katsuya Sakai,
  • Hiroki Sato,
  • Ryu Imamura and
  • Kunio Matsumoto

26 August 2021

NK1, a splicing variant of hepatocyte growth factor (HGF), binds to and activates Met receptor by forming an NK1 dimer and 2:2 complex with Met. Although the structural mechanism underlying Met activation by HGF remains incompletely resolved, it has...

(This article belongs to the Special Issue Hepatocyte Growth Factor (HGF), II)
  • Article
  • Open Access
1 Citations
1,626 Views
12 Pages

Intervention Potential of a Recombinant Tarim Red Deer HGF Protein in a Mouse Model of Alcoholic Liver Disease

  • Hong Chen,
  • Chuan Lin,
  • Xin Xiang,
  • Chenchen Yang and ,
  • Chunmei Han and
  • Qinghua Gao
  • + 1 author+ 0 author

30 June 2025

This study investigates the recombinant Tarim red deer hepatocyte growth factor (HGF) in a mouse model to develop an HGF/c-Met-based regenerative therapy for alcoholic liver disease. We constructed a recombinant HGF fusion protein and expressed and p...

  • Article
  • Open Access
22 Citations
4,760 Views
14 Pages

HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings

  • Verena Boschert,
  • Jonas Teusch,
  • Anwar Aljasem,
  • Philipp Schmucker and ,
  • Nicola Klenk,
  • Anton Straub,
  • Max Bittrich,
  • Axel Seher,
  • Christian Linz and
  • Stefan Hartmann
  • + 6 authors+ 1 author

20 November 2020

Head and neck squamous cell carcinoma (HNSCC) is a widespread disease with a low survival rate and a high risk of recurrence. Nowadays, immune checkpoint inhibitor (ICI) treatment is approved for HNSCC as a first-line treatment in recurrent and metas...

(This article belongs to the Special Issue Squamous Cell Cancer of the Head and Neck—Time to Arrive in the 21st Century of Oncology)
  • Review
  • Open Access
67 Citations
7,867 Views
13 Pages

24 October 2018

The extracellular matrix (ECM) is a crucial component of the tumor microenvironment involved in numerous cellular processes that contribute to cancer progression. It is acknowledged that tumor–stromal cell communication is driven by a complex a...

(This article belongs to the Special Issue Hepatocyte Growth Factor (HGF))
  • Article
  • Open Access
4 Citations
2,670 Views
14 Pages

Differential Immune Checkpoint Protein Expression in HNSCC: The Role of HGF/MET Signaling

  • Verena Boschert,
  • Johannes Boenke,
  • Ann-Kathrin Böhm,
  • Jonas Teusch and ,
  • Valentin Steinacker,
  • Anton Straub and
  • Stefan Hartmann
  • + 2 authors+ 0 author

Although inhibitors targeting the PD1/PD-L1 immune checkpoint are showing comparably good outcomes, a significant percentage of head and neck squamous cell carcinoma (HNSCC) patients do not respond to treatment. Apart from using different treatment s...

(This article belongs to the Special Issue Pathogenesis and Therapy of Oral Carcinogenesis, 2nd Edition)
  • Article
  • Open Access
7 Citations
3,468 Views
12 Pages

The Interplay between HGF/c-met Axis and Nox4 in BRAF Mutated Melanoma

  • Francesca Beretti,
  • Francesca Farnetani,
  • Luca Reggiani Bonetti,
  • Luca Fabbiani and ,
  • Manuela Zavatti,
  • Antonino Maiorana,
  • Giovanni Pellacani and
  • Tullia Maraldi
  • + 3 authors+ 0 author

Background: Melanoma is the leading cause of death due to cutaneous malignancy and its incidence is on the rise. Several signaling pathways, including receptor tyrosine kinases, have a role in the development and progression of melanocytic lesions an...

(This article belongs to the Special Issue Strategies to Counteract Oxidative Stress and Inflammation in Chronic-Degenerative Diseases)
  • Article
  • Open Access
28 Citations
4,921 Views
17 Pages

The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma

  • Verena Boschert,
  • Nicola Klenk,
  • Alexander Abt,
  • Sudha Janaki Raman and ,
  • Markus Fischer,
  • Roman C. Brands,
  • Axel Seher,
  • Christian Linz,
  • Urs D. A. Müller-Richter and
  • Stefan Hartmann
  • + 6 authors+ 1 author

Head and neck squamous cell carcinoma (HNSCC) is known to overexpress a variety of receptor tyrosine kinases, such as the HGF receptor Met. Like other malignancies, HNSCC involves a mutual interaction between the tumor cells and surrounding tissues a...

(This article belongs to the Special Issue New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies)
  • Review
  • Open Access
47 Citations
13,063 Views
32 Pages

7 January 2013

Hepatocyte growth factor (HGF) was discovered in 1984 as a mitogen of rat hepatocytes in a primary culture system. In the mid-1980s, MET was identified as an oncogenic mutant protein that induces malignant phenotypes in a human cell line. In the earl...

(This article belongs to the Special Issue Advances in Molecular Oncology (special issue))
  • Article
  • Open Access
15 Citations
3,556 Views
14 Pages

The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells

  • Masanobu Tsubaki,
  • Shiori Seki,
  • Tomoya Takeda,
  • Akiko Chihara and ,
  • Yuuko Arai,
  • Yuusuke Morii,
  • Motohiro Imano,
  • Takao Satou,
  • Kazunori Shimomura and
  • Shozo Nishida
  • + 5 authors+ 0 author

24 October 2020

Multiple myeloma (MM)-induced bone disease occurs through hyperactivation of osteoclasts by several factors secreted by MM cells. MM cell-secreted factors induce osteoclast differentiation and activation via direct and indirect actions including enha...

(This article belongs to the Special Issue Multiple Myeloma Bone Disease—Symptoms, Diagnosis and Treatment)
  • Article
  • Open Access
1 Citations
1,295 Views
10 Pages

CRISPR/Cas9-Mediated Overexpression of HGF Potentiates Tarim Red Deer Antler MSCs into Osteogenic Differentiation

  • Yujiao Qi,
  • Xiaodong Jia,
  • Chuan Lin,
  • Wenxi Qian and ,
  • Hong Chen,
  • Di Fang and
  • Chunmei Han
  • + 2 authors+ 0 author

26 August 2025

Previous studies conducted by our research groups have demonstrated that the HGF/c-Met signaling pathway promotes the proliferation and migration of MSCs in the antlers of Tarim red deer. However, the role and mechanism of this gene in the osteogenic...

(This article belongs to the Section Biochemistry)
  • Case Report
  • Open Access
3 Citations
2,739 Views
7 Pages

A HGF Mutation in the Familial Case of Primary Lymphedema: A Report

  • Galina Koksharova,
  • Natalia Kokh,
  • Maria Gridina,
  • Rustam Khapaev and ,
  • Vadim Nimaev and
  • Veniamin Fishman
  • + 1 author+ 0 author

Lymphedema is a disorder that leads to excessive swelling due to lymphatic insufficiency, resulting in the accumulation of protein-rich interstitial fluid. Primary lymphedema predominantly impacts the lower extremities and is frequently linked to her...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
47 Citations
5,594 Views
20 Pages

HGF and TSG-6 Released by Mesenchymal Stem Cells Attenuate Colon Radiation-Induced Fibrosis

  • Benoît Usunier,
  • Clément Brossard,
  • Bruno L’Homme,
  • Christine Linard and ,
  • Marc Benderitter,
  • Fabien Milliat and
  • Alain Chapel
  • + 2 authors+ 0 author

11 February 2021

Fibrosis is a leading cause of death in occidental states. The increasing number of patients with fibrosis requires innovative approaches. Despite the proven beneficial effects of mesenchymal stem cell (MSC) therapy on fibrosis, there is little evide...

(This article belongs to the Special Issue Unraveling the Molecular Mechanisms of Mesenchymal Stem Cells Protective Action)
  • Review
  • Open Access
28 Citations
6,519 Views
17 Pages

MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk

  • Chiara Modica,
  • Dora Tortarolo,
  • Paolo M. Comoglio,
  • Cristina Basilico and
  • Elisa Vigna

7 December 2018

The ‘onco-receptor’ MET (Hepatocyte Growth Factor Receptor) is involved in the activation of the invasive growth program that is essential during embryonic development and critical for wound healing and organ regeneration during adult lif...

(This article belongs to the Special Issue Hepatocyte Growth Factor (HGF))
  • Article
  • Open Access
12 Citations
3,214 Views
21 Pages

The PI3K/AKT Pathway Is Activated by HGF in NT2D1 Non-Seminoma Cells and Has a Role in the Modulation of Their Malignant Behavior

  • Luisa Gesualdi,
  • Erica Leonetti,
  • Alessandra Cucina,
  • Bianca Maria Scicchitano and ,
  • Silvia Sorrentino,
  • Maria Grazia Tarsitano,
  • Andrea Isidori,
  • Mariano Bizzarri,
  • Antonio Filippini and
  • Angela Catizone
  • + 9 authors+ 4 authors

17 November 2020

Overactivation of the c-MET/HGF system is a feature of many cancers. We previously reported that type II testicular germ cell tumor (TGCT) cells express the c-MET receptor, forming non-seminomatous lesions that are more positive compared with seminom...

(This article belongs to the Special Issue Hepatocyte Growth Factor (HGF), II)
  • Article
  • Open Access
6 Citations
5,518 Views
17 Pages

MET Activation by a Macrocyclic Peptide Agonist that Couples to Biological Responses Differently from HGF in a Context-Dependent Manner

  • Wenyu Miao,
  • Katsuya Sakai,
  • Ryu Imamura,
  • Kenichiro Ito and ,
  • Hiroaki Suga,
  • Tetsushi Sakuma,
  • Takashi Yamamoto and
  • Kunio Matsumoto
  • + 3 authors+ 0 author

12 October 2018

Non-native ligands for growth factor receptors with distinct chemical properties and different biological activities have the potential to become therapeutic applications. We previously generated MET/hepatocyte growth factor (HGF) receptor agonists u...

(This article belongs to the Special Issue Hepatocyte Growth Factor (HGF))
  • Article
  • Open Access
5 Citations
3,459 Views
13 Pages

A Potential Mechanism of Tumor Progression during Systemic Infections Via the Hepatocyte Growth Factor (HGF)/c-Met Signaling Pathway

  • Hironori Tsujimoto,
  • Hiroyuki Horiguchi,
  • Yusuke Matsumoto,
  • Risa Takahata and ,
  • Nariyoshi Shinomiya,
  • Takao Yamori,
  • Hiromi Miyazaki,
  • Satoshi Ono,
  • Daizoh Saitoh and
  • Hideki Ueno
  • + 6 authors+ 1 author

Background: Increasing evidence has demonstrated that postoperative infectious complications (PICs) after digestive surgery are significantly associated with negative long-term outcomes; however, precise mechanisms of how PICs affect the poor long-te...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Review
  • Open Access
33 Citations
9,845 Views
11 Pages

Hepatocyte growth factor (HGF)-signaling via Met can induce mitogenic, morphogenic, and motogenic activity in various cell types. Met expression in the immune system is limited to cells with antigen-presenting capacities, including dendritic cells (D...

(This article belongs to the Special Issue New aspects of the Hepatocyte Growth Factor/c-Met System)
  • Article
  • Open Access
1 Citations
3,096 Views
18 Pages

Combined Therapy Targeting MET and Pro-HGF Activation Shows Significant Therapeutic Effect Against Liver Metastasis of CRPC

  • Shoichi Kimura,
  • Satoshi Iwano,
  • Takahiro Akioka,
  • Takahiro Kuchimaru and ,
  • Makiko Kawaguchi,
  • Tsuyoshi Fukushima,
  • Yuichiro Sato,
  • Hiroaki Kataoka,
  • Toshiyuki Kamoto and
  • Atsuro Sawada
  • + 6 authors+ 1 author

The liver is the most lethal metastatic site in castration-resistant prostate cancer (CRPC). Overexpression of MET protein has been reported in CRPC, and MET is an important driver gene in androgen-independent CRPC cells. Mouse CRPC cell line CRTC2 w...

(This article belongs to the Section Molecular Pharmacology)
  • Article
  • Open Access
14 Citations
6,425 Views
14 Pages

A Signaling Crosstalk between BMP9 and HGF/c-Met Regulates Mouse Adult Liver Progenitor Cell Survival

  • Annalisa Addante,
  • Cesáreo Roncero,
  • Nerea Lazcanoiturburu,
  • Rebeca Méndez and ,
  • Laura Almalé,
  • María García-Álvaro,
  • Peter ten Dijke,
  • Isabel Fabregat,
  • Blanca Herrera and
  • Aránzazu Sánchez
  • + 5 authors+ 0 author

19 March 2020

During chronic liver disease, hepatic progenitor cells (HPC, oval cells in rodents) become activated, proliferate, and differentiate into cholangiocytes and/or hepatocytes contributing to the final outcome of the regenerative process in a context-dep...

(This article belongs to the Special Issue TGF-beta/BMP Signaling Pathway)
  • Article
  • Open Access
4 Citations
1,473 Views
19 Pages

HGF Overexpression in Mesenchymal Stromal Cell-Based Cell Sheets Enhances Autophagy-Dependent Cytoprotection and Proliferation to Guard the Epicardial Mesothelium

  • Konstantin Dergilev,
  • Irina Beloglazova,
  • Zoya Tsokolaeva,
  • Ekaterina Azimova and ,
  • Aleria Dolgodvorova,
  • Yulia Goltseva,
  • Maria Boldyreva,
  • Mikhail Menshikov,
  • Dmitry Penkov and
  • Yelena Parfyonova
  • + 5 authors+ 0 author

Epicardial mesothelial cells (EMCs), which form the epicardium, play a crucial role in cardiac homeostasis and repair. Upon damage, EMCs reactivate embryonic development programs, contributing to wound healing, progenitor cell amplification, and regu...

(This article belongs to the Special Issue Fundamental and Practical Perspectives in Regenerative Medicine: Proceedings of the VI National Congress of Regenerative Medicine (2024))
  • Article
  • Open Access
19 Citations
4,790 Views
17 Pages

Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients

  • Juliette Palle,
  • Laure Hirsch,
  • Alexandra Lapeyre-Prost,
  • David Malka and ,
  • Morgane Bourhis,
  • Simon Pernot,
  • Elie Marcheteau,
  • Thibault Voron,
  • Florence Castan and
  • Magali Terme
  • + 14 authors+ 9 authors

5 November 2021

Elucidating mechanisms involved in tumor-induced immunosuppression is of great interest since it could help to improve cancer immunotherapy efficacy. Here we show that Hepatocyte Growth Factor (HGF), a pro-tumoral and proangiogenic factor, and its re...

(This article belongs to the Special Issue Tumor Vasculature and Immunity in Cancer)
  • Article
  • Open Access
10 Citations
4,301 Views
18 Pages

Progranulin A Promotes Compensatory Hepatocyte Proliferation via HGF/c-Met Signaling after Partial Hepatectomy in Zebrafish

  • Keng-Yu Chiang,
  • Ya-Wen Li,
  • Yen-Hsing Li,
  • Shin-Jie Huang and ,
  • Chih-Lu Wu,
  • Hong-Yi Gong and
  • Jen-Leih Wu
  • + 2 authors+ 0 author

18 October 2021

Compensatory hepatocyte proliferation and other liver regenerative processes are activated to sustain normal physiological function after liver injury. A major mitogen for liver regeneration is hepatocyte growth factor (HGF), and a previous study ind...

(This article belongs to the Topic Clinical, Translational and Basic Research on Liver Diseases)
  • Article
  • Open Access
9 Citations
3,726 Views
16 Pages

Hepatocyte growth factor (HGF) and transforming growth factor β1 (TGFβ1) are biological stimuli of the micro-environment which affect bone metastasis phenotype through transcription factors, but their influence on the growth is scarcely kno...

(This article belongs to the Special Issue Tumor Microenvironment 2019)
  • Review
  • Open Access
36 Citations
7,602 Views
28 Pages

Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment

  • Shuxi Yao,
  • Xinyue Liu,
  • Yanqi Feng,
  • Yiming Li and ,
  • Xiangtian Xiao,
  • Yuelin Han and
  • Shu Xia
  • + 2 authors+ 0 author

22 August 2024

Non-small cell lung cancer (NSCLC) is characterized by several molecular alterations that contribute to its development and progression. These alterations include the epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), human ep...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
2 Citations
2,657 Views
21 Pages

ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation

  • Luisa Gesualdi,
  • Marika Berardini,
  • Bianca Maria Scicchitano,
  • Clotilde Castaldo and ,
  • Mariano Bizzarri,
  • Antonio Filippini,
  • Anna Riccioli,
  • Chiara Schiraldi,
  • Francesca Ferranti and
  • Angela Catizone
  • + 8 authors+ 3 authors

c-MET/hepatocyte growth factor (HGF) system deregulation is a well-known feature of malignancy in several solid tumors, and for this reason this system and its pathway have been considered as potential targets for therapeutic purposes. In previous ma...

(This article belongs to the Special Issue Tumor Microenvironment and Cancer Therapy)
  • Article
  • Open Access
10 Citations
4,707 Views
25 Pages

Intracoronary Delivery of Porcine Cardiac Progenitor Cells Overexpressing IGF-1 and HGF in a Pig Model of Sub-Acute Myocardial Infarction

  • Cristina Prat-Vidal,
  • Verónica Crisóstomo,
  • Isabel Moscoso,
  • Claudia Báez-Díaz and ,
  • Virginia Blanco-Blázquez,
  • Guadalupe Gómez-Mauricio,
  • Guillermo Albericio,
  • Susana Aguilar,
  • María-Eugenia Fernández-Santos and
  • Antonio Bernad
  • + 8 authors+ 3 authors

28 September 2021

Human cardiac progenitor cells (hCPC) are considered a good candidate in cell therapy for ischemic heart disease, demonstrating capacity to improve functional recovery after myocardial infarction (MI), both in small and large preclinical animal model...

(This article belongs to the Collection Stem Cells in Tissue Engineering and Regeneration)
  • Article
  • Open Access
15 Citations
4,865 Views
23 Pages

Therapeutic Angiogenesis by a “Dynamic Duo”: Simultaneous Expression of HGF and VEGF165 by Novel Bicistronic Plasmid Restores Blood Flow in Ischemic Skeletal Muscle

  • Ekaterina Slobodkina,
  • Maria Boldyreva,
  • Maxim Karagyaur,
  • Roman Eremichev and ,
  • Natalia Alexandrushkina,
  • Vadim Balabanyan,
  • Zhanna Akopyan,
  • Yelena Parfyonova,
  • Vsevolod Tkachuk and
  • Pavel Makarevich
  • + 5 authors+ 0 author

Therapeutic angiogenesis is a promising strategy for relief of ischemic conditions, and gene delivery was used to stimulate blood vessels’ formation and growth. We have previously shown that intramuscular injection of a mixture containing plasm...

(This article belongs to the Section Gene and Cell Therapy)
  • Article
  • Open Access
1 Citations
2,547 Views
17 Pages

Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination

  • Chiara Modica,
  • Marco Cortese,
  • Francesca Bersani,
  • Andrea Maria Lombardi and ,
  • Francesca Napoli,
  • Luisella Righi,
  • Riccardo Taulli,
  • Cristina Basilico and
  • Elisa Vigna
  • + 4 authors+ 0 author

13 May 2023

Cancer cell dissemination is sustained by cell-autonomous and non-cell-autonomous functions. To disentangle the role of HGF (Hepatocyte Growth Factor) and MET ligand/receptor axis in this complex process, we genetically knocked out the MET gene in ca...

(This article belongs to the Special Issue The Biological Mechanism of Cancer Proliferation and Metastasis)
  • Article
  • Open Access
5,380 Views
14 Pages

HGF and VEGF-A and Their Receptors Show Expression and Angiogenic Effects on Human Choroidal Endothelial Cells: Implications for Treatments of Neovascular Age-Related Macular Degeneration

  • Elizabeth A. Stewart,
  • Claire L. Allen,
  • Govindi J. Samaranayake,
  • Thomas Stubington and ,
  • Rukhsar Akhtar,
  • Matthew J. Branch and
  • Winfried M. Amoaku
  • + 2 authors+ 0 author

Intraocular neovascularisation is associated with common blinding conditions including neovascular age-related macular degeneration (nAMD). Vascular endothelial growth factor (VEGF) is central in driving choroidal neovascularisation in this disease....

  • Article
  • Open Access
7 Citations
3,911 Views
15 Pages

The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3

  • Simona Gallo,
  • Martina Spilinga,
  • Elena Casanova,
  • Alessandro Bonzano and ,
  • Carla Boccaccio,
  • Paolo Maria Comoglio and
  • Tiziana Crepaldi
  • + 2 authors+ 0 author

Previous studies showed that the hepatocyte growth factor (HGF)–Met receptor axis plays long-lasting cardioprotection against doxorubicin anti-cancer therapy. Here, we explored the mechanism(s) underlying the HGF protective effect. DNA damage w...

(This article belongs to the Special Issue MAPK-ERK Pathway)
  • Article
  • Open Access
7 Citations
5,278 Views
9 Pages

Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling

  • Xiwei Ji,
  • Xiangrui Meng,
  • Qingfeng He,
  • Xiaoqiang Xiang and ,
  • Yufei Shi and
  • Xiao Zhu
  • + 1 author+ 0 author

This study investigated the antitumor effects of foretinib on triple-negative breast cancer cells MDA-MB-231 xenograft tumors in vivo underlying phosphorylated mesenchymal to epithelial transition (p-MET)/ hepatocyte growth factor (HGF)-related mecha...

(This article belongs to the Special Issue Molecular Targets for Antiviral and Anticancer Drugs)

of 16